McNutt Ex Rel. United States v. Haleyville Medical Supplies, Inc.

423 F.3d 1256, 2005 U.S. App. LEXIS 19482, 2005 WL 2179164
CourtCourt of Appeals for the Eleventh Circuit
DecidedSeptember 9, 2005
Docket04-14458
StatusPublished
Cited by65 cases

This text of 423 F.3d 1256 (McNutt Ex Rel. United States v. Haleyville Medical Supplies, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McNutt Ex Rel. United States v. Haleyville Medical Supplies, Inc., 423 F.3d 1256, 2005 U.S. App. LEXIS 19482, 2005 WL 2179164 (11th Cir. 2005).

Opinion

PRYOR, Circuit Judge:

The question in this interlocutory appeal is whether a violation of the Anti-Kickback Statute can form the basis for a qui tam action under the False Claims Act. Gerald and Frances Burleson routinely provided medical services for which they submitted claims for reimbursement to Medicare, and each year, the Burlesons certified that they complied with the Anti-Kickback Statute. Because it is undisputed that a violator of the Anti-Kickback Statute is disqualified from participating in a Medicare program, the government stated a claim, under the False Claims Act, when it alleged that the Burlesons had submitted claims for Medicare reimbursement with knowledge that they were ineligible for that reimbursement. We affirm the district court.

I. BACKGROUND

In December 2001, Brent McNutt, a former employee of a medical services company owned by the Burlesons, filed a qui tam action against the Burlesons and five medical services companies that they owned, Haleyville Medical Supplies, City Pharma *1258 cy, Care Medical, Care Pharmacy, and Winfield Medical, for violations of the False Claims Act. 31 U.S.C. § 3729(a). In 2002, the United States Attorney for the Northern District of Alabama opened parallel criminal and civil investigations of the Burlesons’ activities. The district court ordered a stay of discovery pending the criminal investigation and any later criminal proceeding, unless all defendants waived their Fifth Amendment privilege against self-incrimination.

The government filed a complaint in intervention. The government alleged that Medicare providers are required to enter a provider agreement with the government, and under the terms of the agreement, the Medicare provider certifies that it will comply with all laws and regulations concerning proper practices for Medicare providers. One of the laws included in this certification is the Anti-Kickback Statute. 42 U.S.C. § 1320a-7b(b). The government alleged that a Medicare “provider’s compliance with its provider agreement is a condition for receipt of payments from the Medicare program.”

The government also alleged detailed facts about the Burlesons’ activities. The government alleged that the companies owned by the Burlesons were Medicare providers and the Burlesons violated the Anti-Kickback Statute by paying kickbacks camouflaged as rental payments and commissions to pharmacists and other individuals. The Burlesons issued monthly checks to referring pharmacists. The amount of the checks were a percentage, typically 20 to 25 percent, of the amount the Burlesons received from Medicare for services provided to the patients referred by those pharmacists. To conceal the nature of the kickback payments, the Burle-sons characterized each check as “rent” in the “memo” portion of the check.

The government also alleged that the Burlesons paid kickbacks to two respiratory therapists and a doctor’s patient representative for referring Medicare patients to the Burlesons. The government identified specific claims submitted by the Burlesons to Medicare for reimbursement for services, which had been rendered to patients referred by the individuals receiving kickbacks:

An example of such a transaction is found in Patient A, who received a prescription dated April 24, 2001. Burleson submitted the claim form on June 11 and/or 13, 2001 for reimbursement for patient A. Another example of the said transactions is found in Patient B who received a prescription dated September 30, 2001. Burleson submitted the claim form on November 16, 2001. Vicky Wesson received a commission for the referral of patients A and B.
Patient C ... received a prescription dated August 18, 1999. Burleson submitted the claim form on November 17, 1999, for reimbursement for Patient C - Patient D ... received a prescription dated February 26, 1999. Burleson submitted the claim form on March 10, 1999. Higgins received commissions on the referral of patients C and D.

The government alleged that, by virtue of these acts, the Burlesons knowingly presented, or knowingly caused to be presented, false or fraudulent claims for payment in violation of the False Claims Act.

The Burlesons filed a motion to dismiss for failure to state a claim upon which relief could be granted. The district court denied the motion, but encouraged the Burlesons to request the court to certify the question for interlocutory appeal. After the Burlesons filed that request, the district court certified the following question for interlocutory appeal: “whether a violation of the Anti-Kickback Statute, 42 U.S.C. § 1320a — 7b(b)[,] can form a basis *1259 for a claim pursuant to the False Claim[s] Act, 31 U.S.C. § 3729(a)(1) and 31 U.S.C. § 3729(a)(3).” This Court then granted the Burlesons’ petition for interlocutory appeal.

II. STANDARD OF REVIEW

We review de novo questions of statutory interpretation and the denial of a motion to dismiss for failure to state a claim. See Swann v. S. Health Partners, Inc., 388 F.3d 834, 835 (11th Cir.2004); Rodriguez v. Lamer, 60 F.3d 745, 747 (11th Cir.1995). Because this appeal is from the denial of a motion to dismiss for failure to state a claim, we “view the allegations of the complaint in the light most favorable to the plaintiff! ], consider the allegations of the complaint as true, and accept all reasonable inferences therefrom.” Tello v. Dean Witter Reynolds, Inc., 410 F.3d 1275, 1288 n. 12 (11th Cir.2005).

III. DISCUSSION

The False Claims Act is the primary law on which the federal government relies to recover losses caused by fraud. Avco Corp. v. U.S. Dept. of Justice, 884 F.2d 621, 622 (D.C.Cir.1989). The Act creates civil liability for making a false claim for payment by the government:

Any person wlm — ■
(1) knowingly presents, or causes to be presented, to an officer or employee of the United States Government or a member of the Armed Forces of the United States a false or fraudulent claim for payment or approval; [or]
conspires to defraud the Government by getting a false or fraudulent claim allowed or paid;
is liable to the United States Government. ...

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
423 F.3d 1256, 2005 U.S. App. LEXIS 19482, 2005 WL 2179164, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mcnutt-ex-rel-united-states-v-haleyville-medical-supplies-inc-ca11-2005.